{"id":47248,"date":"2019-02-08T11:23:05","date_gmt":"2019-02-08T15:53:05","guid":{"rendered":"https:\/\/piel-l.org\/blog\/?p=47248"},"modified":"2019-02-08T19:41:39","modified_gmt":"2019-02-09T00:11:39","slug":"dermatologia-de-enlace-edicion-no-438-eritema-flagelado","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/47248","title":{"rendered":"Dermatolog\u00eda de enlace Edici\u00f3n N\u00ba 438: Eritema flagelado"},"content":{"rendered":"<p><strong>Ismery Cabello<\/strong><br \/>\nDermat\u00f3logo-Dermatopat\u00f3logo<br \/>\nUDO. N\u00facleo Bol\u00edvar<\/p>\n<p>Efecto adverso espec\u00edfico de la Bleomicina<br \/>\nCl\u00ednica: bandas lineales con predominio de aspecto flagelado<br \/>\nLocalizaci\u00f3n: predominan en tronco y region proximal de extremidades<br \/>\nEtiopatogenia: es incierta<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2019\/02\/ed438-enlace-image-1-576x1024.jpg\" alt=\"\" width=\"576\" height=\"1024\" class=\"aligncenter size-large wp-image-47249\" srcset=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2019\/02\/ed438-enlace-image-1.jpg 576w, https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2019\/02\/ed438-enlace-image-1-270x480.jpg 270w\" sizes=\"auto, (max-width: 576px) 100vw, 576px\" \/><\/p>\n<p>Frecuencia: de 10 % a 30 % de los casos que reciben Bleomicina<br \/>\nIndependiente de: la dosis recibida, la v\u00eda de administraci\u00f3n y de la naturaleza de la lesi\u00f3n tratada<br \/>\nEvoluci\u00f3n: resoluci\u00f3n espont\u00e1nea con pigmentaci\u00f3n residual o esclerosis<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2019\/02\/ed438-enlace-image-2-576x1024.jpg\" alt=\"\" width=\"576\" height=\"1024\" class=\"aligncenter size-large wp-image-47250\" srcset=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2019\/02\/ed438-enlace-image-2.jpg 576w, https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2019\/02\/ed438-enlace-image-2-270x480.jpg 270w\" sizes=\"auto, (max-width: 576px) 100vw, 576px\" \/><\/p>\n<p>Puede observarse como signos cl\u00ednicos en Dermatomiositis y Esclerodermia<br \/>\nDiagn\u00f3stico diferencial: Dermatitis flagelada posterior a la ingesta de hongo shiitake, dermatitis artefacta, dermatitis por contacto, fen\u00f3meno de Koebner, dermografismo<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2019\/02\/ed438-enlace-image-3-576x1024.jpg\" alt=\"\" width=\"576\" height=\"1024\" class=\"aligncenter size-large wp-image-47251\" srcset=\"https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2019\/02\/ed438-enlace-image-3.jpg 576w, https:\/\/piel-l.org\/blog\/wp-content\/uploads\/2019\/02\/ed438-enlace-image-3-270x480.jpg 270w\" sizes=\"auto, (max-width: 576px) 100vw, 576px\" \/><\/p>\n<p>Histolog\u00eda: paraqueratosis, espongiosis, leve infiltrado linfohistiocitario perivascular, presencia de eosin\u00f3filos<br \/>\nEn conclusi\u00f3n: el Eritema flagelado es considerado como complicaci\u00f3n espec\u00edfica de la Bleomicina, descrito por vez primera en 1970 por Moulin.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Efecto adverso espec\u00edfico de la Bleomicina<br \/>\nCl\u00ednica: bandas lineales con predominio de aspecto flagelado<br \/>\nLocalizaci\u00f3n: predominan en tronco y region proximal de extremidades<br \/>\nEtiopatogenia: es incierta<\/p>\n","protected":false},"author":104,"featured_media":47249,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[252],"tags":[],"class_list":["post-47248","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-psicodermatosis"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/47248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/104"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=47248"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/47248\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media\/47249"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=47248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=47248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=47248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}